MetLife (MET) Misses Q4 EPS by 13c
Tweet
Share
E-mail
Get Alerts MET Hot Sheet
Price: $95.50 -2.17%
Revenue Growth %: +15.8%
Financial Fact:
Interest credited to policyholder account balances: 1.82B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Interest credited to policyholder account balances: 1.82B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q4 EPS of $1.55, $0.13 worse than the analyst estimate of $1.68. Revenue for the quarter came in at $16.3 billion versus the consensus estimate of $17.18 billion.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
